Beit Jala Pharmaceutical Co (XPAE:BJP) EBITDA Margin %: 0.00% (As of . 20)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Beit Jala Pharmaceutical Co EBITDA Margin %?

Beit Jala Pharmaceutical Co XPAE:BJP EBITDA Margin % is 0.00% as of . 20. The stock has 1 warning sign investors should review.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Beit Jala Pharmaceutical Co's EBITDA for the six months ended in . 20 was JOD0.00 Mil. Beit Jala Pharmaceutical Co's Revenue for the six months ended in . 20 was JOD0.00 Mil. Therefore, Beit Jala Pharmaceutical Co's EBITDA margin for the quarter that ended in . 20 was 0.00%.

Beit Jala Pharmaceutical Co  (XPAE:BJP) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Beit Jala Pharmaceutical Co EBITDA Margin % Related Terms

Beit Jala Pharmaceutical Co EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for Beit Jala Pharmaceutical Co's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Beit Jala Pharmaceutical Co EBITDA Margin % Chart

Beit Jala Pharmaceutical Co Annual Data
Trend
EBITDA Margin %

Beit Jala Pharmaceutical Co Semi-Annual Data
EBITDA Margin %

XPAE:BJP vs : EBITDA Margin % Comparison

For the Biotechnology subindustry, Beit Jala Pharmaceutical Co's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Beit Jala Pharmaceutical Co EBITDA Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Beit Jala Pharmaceutical Co's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Beit Jala Pharmaceutical Co's EBITDA Margin % falls into.


Beit Jala Pharmaceutical Co EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Beit Jala Pharmaceutical Co's EBITDA Margin % for the fiscal year that ended in . 20 is calculated as

EBITDA Margin %=EBITDA (A: . 20 )/Revenue (A: . 20 )
=/
= %

Beit Jala Pharmaceutical Co's EBITDA Margin % for the quarter that ended in . 20 is calculated as

EBITDA Margin %=EBITDA (Q: . 20 )/Revenue (Q: . 20 )
=/
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA Margin % →
What does a EBITDA Margin % of 0.00% mean?
Beit Jala Pharmaceutical Co (XPAE:BJP) has a EBITDA Margin % of 0.00% as of . 20. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Beit Jala Pharmaceutical Co and its competitors.
Is Beit Jala Pharmaceutical Co's EBITDA Margin % too high?
Beit Jala Pharmaceutical Co's current EBITDA Margin % is 0.00%.
How does Beit Jala Pharmaceutical Co's EBITDA Margin % compare to ?
Beit Jala Pharmaceutical Co's EBITDA Margin % of 0.00% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Biotechnology company?
A good EBITDA Margin % depends on the Biotechnology industry context. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Beit Jala Pharmaceutical Co and its competitors. Beit Jala Pharmaceutical Co's current EBITDA Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Beit Jala Pharmaceutical Co stock overvalued right now?
Beit Jala Pharmaceutical Co (XPAE:BJP) has a current EBITDA Margin % of 0.00%. The current EBITDA Margin % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Beit Jala Pharmaceutical Co (XPAE:BJP), the current EBITDA Margin % is 0.00% as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Beit Jala Pharmaceutical Co Business Description

Comparable Companies
Address 81, Al-Madares Street, Beit Jala, West Bank, Beit Jala, PSE, 97300
Beit Jala Pharmaceutical Co is a manufacturer of pharmaceutical products. The company's products include tablets, capsules, powders, syrups, solutions, oral drops, creams, gels, lotions, medicated shampoo, suppositories and ointments.